Related Herbs
Botanicals connected by the same goals, effects, or research topics.
We use privacy-friendly analytics. Read our privacy policy.
Compound Profile
Acarbose carries a Grade C rating — limited evidence.
Use extra caution — Flatulence, diarrhea, and abdominal discomfort common; caution inflammatory bowel disease and significant renal impairment. Details
Safety
Flatulence, diarrhea, and abdominal discomfort common; caution inflammatory bowel disease and significant renal impairment.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Blood-sugar lowering
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 110 of 110 pairings in this mechanism group.
+98 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Read as directional context, not settled clinical proof.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · Glucose Metabolism Support · Glucose Metabolism
Research maturity: Emerging research — main contexts: Metabolic Health · Inflammation · Digestive Health
Safety boundary: Safety note available — Flatulence, diarrhea, and abdominal discomfort common; caution inflammatory bowel disease and significant renal impairment.
This profile cites 1 human study.
Confidence estimate based on the design quality and consistency of published clinical trials.
Acarbose has a limited evidence rating.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
What the evidence actually shows
This table contains 1 structured source, including 1 human evidence source; 1 is a human trial. Across 1 human evidence source with a reported sample size, the approximate participant total is 1,946; overlapping publications may include some of the same people.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
PubMed · Diabetes Care · 1999 Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | n=1946 | — | — | — | — | — | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Acarbose Works
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Condition guides
Continue exploring
Botanicals connected by the same goals, effects, or research topics.
Compounds connected by the same goals, effects, or research topics.
Deeper context, comparisons, and practical research paths.
Safety checks and cautions relevant to this decision.
Deeper context, comparisons, and practical research paths.
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Free safety checklist
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?